Evidence map›Paper›PMID 31619292›Full record

ArticleActa neuropathologica communications2019

Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells.

Mirca S Saurty-Seerunghen, Léa Bellenger, Elias A El-Habr, Virgile Delaunay, Delphine Garnier, Hervé Chneiweiss, Christophe Antoniewski, Ghislaine Morvan-Dubois, Marie-Pierre Junier

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Case of multifocal glioblastoma with four fusion transcripts ofCold Spring Harbor molecular case studies · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mirca S Saurty-SeerunghenCNRS UMR8246, Inserm U1130, Sorbonne Université, Neuroscience Paris Seine-IBPS, Team glial plasticity and neurooncology, Paris, France.
Léa BellengerARTbio Bioinformatics Analysis Facility, Sorbonne Université, CNRS, Institut de Biologie Paris Seine, 75005, Paris, France.
Elias A El-HabrCNRS UMR8246, Inserm U1130, Sorbonne Université, Neuroscience Paris Seine-IBPS, Team glial plasticity and neurooncology, Paris, France.
Virgile DelaunayCNRS UMR8246, Inserm U1130, Sorbonne Université, Neuroscience Paris Seine-IBPS, Team glial plasticity and neurooncology, Paris, France.
Delphine GarnierCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Sorbonne Université, INSERM UMRS 1138, 75005, Paris, France.
Hervé ChneiweissCNRS UMR8246, Inserm U1130, Sorbonne Université, Neuroscience Paris Seine-IBPS, Team glial plasticity and neurooncology, Paris, France. herve.chneiweiss@inserm.fr.
Christophe AntoniewskiARTbio Bioinformatics Analysis Facility, Sorbonne Université, CNRS, Institut de Biologie Paris Seine, 75005, Paris, France.
Ghislaine Morvan-DuboisCNRS UMR8246, Inserm U1130, Sorbonne Université, Neuroscience Paris Seine-IBPS, Team glial plasticity and neurooncology, Paris, France. ghislaine.morvan-dubois@upmc.fr.
Marie-Pierre JunierCNRS UMR8246, Inserm U1130, Sorbonne Université, Neuroscience Paris Seine-IBPS, Team glial plasticity and neurooncology, Paris, France. marie-pierre.junier@inserm.fr.ORCID 0000-0002-5731-0929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma cell ability to adapt their functioning to microenvironment changes is a source of the extensive intra-tumor heterogeneity characteristic of this devastating malignant brain tumor. A systemic view of the metabolic pathways underlying glioblastoma cell functioning states is lacking. We analyzed public single cell RNA-sequencing data from glioblastoma surgical resections, which offer the closest available view of tumor cell heterogeneity as encountered at the time of patients' diagnosis. Unsupervised analyses revealed that information dispersed throughout the cell transcript repertoires encoded the identity of each tumor and masked information related to cell functioning states. Data reduction based on an experimentally-defined signature of transcription factors overcame this hurdle. It allowed cell grouping according to their tumorigenic potential, regardless of their tumor of origin. The approach relevance was validated using independent datasets of glioblastoma cell and tissue transcriptomes, patient-derived cell lines and orthotopic xenografts. Overexpression of genes coding for amino acid and lipid metabolism enzymes involved in anti-oxidative, energetic and cell membrane processes characterized cells with high tumorigenic potential. Modeling of their expression network highlighted the very long chain polyunsaturated fatty acid synthesis pathway at the core of the network. Expression of its most downstream enzymatic component, ELOVL2, was associated with worsened patient survival, and required for cell tumorigenic properties in vivo. Our results demonstrate the power of signature-driven analyses of single cell transcriptomes to obtain an integrated view of metabolic pathways at play within the heterogeneous cell landscape of patient tumors.

Indexed as

Amino AcidsBrain NeoplasmsCluster AnalysisGene Expression Regulation, NeoplasticGlioblastomaHumansLipid MetabolismSingle-Cell AnalysisAmino AcidsComputational modelingElongaseGliomaPUFAscRNA-seq

Identifiers

PMID31619292
PMCPMC6796454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.